Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Elsevier Science full text link Elsevier Science Free PMC article
Full text links

Actions

Share

Review
.2017 Mar;42(3):206-218.
doi: 10.1016/j.tibs.2016.10.001. Epub 2016 Nov 2.

Regulation of DNA Alkylation Damage Repair: Lessons and Therapeutic Opportunities

Affiliations
Review

Regulation of DNA Alkylation Damage Repair: Lessons and Therapeutic Opportunities

Jennifer M Soll et al. Trends Biochem Sci.2017 Mar.

Abstract

Alkylation chemotherapy is one of the most widely used systemic therapies for cancer. While somewhat effective, clinical responses and toxicities of these agents are highly variable. A major contributing factor for this variability is the numerous distinct lesions that are created upon alkylation damage. These adducts activate multiple repair pathways. There is mounting evidence that the individual pathways function cooperatively, suggesting that coordinated regulation of alkylation repair is critical to prevent toxicity. Furthermore, some alkylating agents produce adducts that overlap with newly discovered methylation marks, making it difficult to distinguish between bona fide damaged bases and so-called 'epigenetic' adducts. Here, we discuss new efforts aimed at deciphering the mechanisms that regulate these repair pathways, emphasizing their implications for cancer chemotherapy.

Keywords: AlkB; MGMT; alkylation chemotherapy; base excision repair.

Copyright © 2016 Elsevier Ltd. All rights reserved.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Biochemical mechanisms of alkylation damage repair regulation relevant to tumor therapy
(A)MGMT gene silencing by DNA methylation leads to improved tumor responses to monomethylating agents such as TMZ.(B) Loss of mismatch repair leads to increased transition mutations, which may create higher rates of neoantigen expression upon alkylation damage. A combination of alkylation chemotherapy and immune checkpoint blockade may be effective.(C) Expression of mutant DNA Polβ may result in an imbalance in BER. In certain cases of imbalanced BER, inhibition of PARP or PARG may be a viable therapeutic.(D) Increased expression of ALKBH2/3 due to the OTUD4/USP7/USP9X deubiquitinase pathway may be countered using small molecule inhibitors against USP7 or USP9X.(E) IDH mutant tumors express the oncometabolite 2-hydroxyglutarate, which inhibits AlkB type demethylases. In these tumors the alkylating agent busulfan or chlorethylating alkylating agents may be more effective.
Figure 2
Figure 2. Potential mechanisms of alkylation damage-induced ‘epigenetic confusion’
(A) 1-meA is associated with 5’ UTRs of actively translated mRNAs. Induction of alkylation damage may hinder translation if 1-meA is present in the mRNA coding region.(B) Formation of 6meA from 1meA through Dimroth rearrangement. In the chromatin environment, residues such as lysine may promote nucleophilic attack of 1meA, leading to a ring-opened intermediate, which rearranges to form 6meA. As 6meA may have an epigenetic role in DNA, this conversion may lead to its inappropriate placement and function.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Fu D, et al. Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat Rev Cancer. 2012;12:104–120. - PMC - PubMed
    1. Rydberg B, Lindahl T. Nonenzymatic methylation of DNA by the intracellular methyl group donor S-adenosyl-L-methionine is a potentially mutagenic reaction. The EMBO journal. 1982;1:211–216. - PMC - PubMed
    1. Drablos F, et al. Alkylation damage in DNA and RNA--repair mechanisms and medical significance. DNA Repair (Amst) 2004;3:1389–1407. - PubMed
    1. Beranek DT. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat Res. 1990;231:11–30. - PubMed
    1. Gentil A, et al. Mutagenicity of a unique apurinic/apyrimidinic site in mammalian cells. J Mol Biol. 1992;227:981–984. - PubMed

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full text links
Elsevier Science full text link Elsevier Science Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp